123 related articles for article (PubMed ID: 22404851)
1. Intraindividual cognitive decline using a brief computerized cognitive screening test.
Darby DG; Pietrzak RH; Fredrickson J; Woodward M; Moore L; Fredrickson A; Sach J; Maruff P
Alzheimers Dement; 2012; 8(2):95-104. PubMed ID: 22404851
[TBL] [Abstract][Full Text] [Related]
2. Episodic memory decline predicts cortical amyloid status in community-dwelling older adults.
Darby DG; Brodtmann A; Pietrzak RH; Fredrickson J; Woodward M; Villemagne VL; Fredrickson A; Maruff P; Rowe C
J Alzheimers Dis; 2011; 27(3):627-37. PubMed ID: 21876253
[TBL] [Abstract][Full Text] [Related]
3. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
[TBL] [Abstract][Full Text] [Related]
4. Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS).
Lim YY; Jaeger J; Harrington K; Ashwood T; Ellis KA; Stöffler A; Szoeke C; Lachovitzki R; Martins RN; Villemagne VL; Bush A; Masters CL; Rowe CC; Ames D; Darby D; Maruff P
Arch Clin Neuropsychol; 2013 Jun; 28(4):320-30. PubMed ID: 23552802
[TBL] [Abstract][Full Text] [Related]
5. Aβ and cognitive change: examining the preclinical and prodromal stages of Alzheimer's disease.
Lim YY; Maruff P; Pietrzak RH; Ellis KA; Darby D; Ames D; Harrington K; Martins RN; Masters CL; Szoeke C; Savage G; Villemagne VL; Rowe CC;
Alzheimers Dement; 2014 Nov; 10(6):743-751.e1. PubMed ID: 24589436
[TBL] [Abstract][Full Text] [Related]
6. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment.
Chételat G; Eustache F; Viader F; De La Sayette V; Pélerin A; Mézenge F; Hannequin D; Dupuy B; Baron JC; Desgranges B
Neurocase; 2005 Feb; 11(1):14-25. PubMed ID: 15804920
[TBL] [Abstract][Full Text] [Related]
8. Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
Koivunen J; Karrasch M; Scheinin NM; Aalto S; Vahlberg T; Någren K; Helin S; Viitanen M; Rinne JO
Dement Geriatr Cogn Disord; 2012; 34(1):31-7. PubMed ID: 22868352
[TBL] [Abstract][Full Text] [Related]
9. Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?
Lim YY; Ellis KA; Harrington K; Pietrzak RH; Gale J; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P
J Alzheimers Dis; 2013; 33(4):1167-76. PubMed ID: 23160011
[TBL] [Abstract][Full Text] [Related]
10. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
[TBL] [Abstract][Full Text] [Related]
11. Influence of amyloid and APOE on cognitive performance in a late middle-aged cohort.
Mielke MM; Machulda MM; Hagen CE; Christianson TJ; Roberts RO; Knopman DS; Vemuri P; Lowe VJ; Kremers WK; Jack CR; Petersen RC
Alzheimers Dement; 2016 Mar; 12(3):281-91. PubMed ID: 26602629
[TBL] [Abstract][Full Text] [Related]
12. Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burden.
Rembach A; Watt AD; Wilson WJ; Villemagne VL; Burnham SC; Ellis KA; Maruff P; Ames D; Rowe CC; Macaulay SL; Bush AI; Martins RN; Masters CL; Doecke JD;
J Alzheimers Dis; 2014; 40(1):95-104. PubMed ID: 24334723
[TBL] [Abstract][Full Text] [Related]
13. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
14. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
[TBL] [Abstract][Full Text] [Related]
15. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects.
Schönknecht P; Pantel J; Kruse A; Schröder J
Am J Psychiatry; 2005 Nov; 162(11):2071-7. PubMed ID: 16263846
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
18. Rapid decline in episodic memory in healthy older adults with high amyloid-β.
Lim YY; Pietrzak RH; Ellis KA; Jaeger J; Harrington K; Ashwood T; Szoeke C; Martins RN; Bush AI; Masters CL; Rowe CC; Villemagne VL; Ames D; Darby D; Maruff P
J Alzheimers Dis; 2013; 33(3):675-9. PubMed ID: 23001710
[TBL] [Abstract][Full Text] [Related]
19. Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults.
Lim YY; Ellis KA; Pietrzak RH; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
Neurology; 2012 Oct; 79(16):1645-52. PubMed ID: 23071163
[TBL] [Abstract][Full Text] [Related]
20. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
Villemagne VL; Pike KE; Darby D; Maruff P; Savage G; Ng S; Ackermann U; Cowie TF; Currie J; Chan SG; Jones G; Tochon-Danguy H; O'Keefe G; Masters CL; Rowe CC
Neuropsychologia; 2008; 46(6):1688-97. PubMed ID: 18343463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
